17.02.2016 - In Dr. Pepper Snapple worsened forecasts for 2016

Dr. Company Pepper Snapple on the results of the 4th quarter, reported a net profit of 185 million US dollars, compared with 150 million dollars in the same period of the previous year. During the quarter, sales totaled 1.55 billion dollars against 1.51 billion in Q4, 2014. Sales remained at the same levels in the US and Canada, but rose 6% in Mexico and the Caribbean countries. Profit growth in 2016 according to the company will be only 1%, and the company will spend 1 billion dollars to pay dividends and buy back shares. Despite the likely fall in the near future, we expect growth stocks by 15-20% this year.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.